The US Food and Drug Administration (USFDA) on 14 February approved ‘Banyan Brain Trauma Indicator’ (BBTI), the first-ever blood test for concussions. The approval means marketing authorization for the test which can be now sold commercially. The test was developed by private biotech firm, Banyan Biomarkers. – This test can be used to test for mild traumatic brain injury (mTBI, more commonly called a concussion). This test can slash the number Read More …
